期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

POEMS综合征相关肾损害与血栓性微血管病样肾损害 被引量：4

原文传递
导出
摘要 患行男，36岁，因“反复颜面水肿伴四肢乏力9月”入院．患者2012年3月开始出现颜面浮肿，伴四肢乏力，偶有肢端麻木感，双侧对称，遇冷时明显。同时伴性欲减退，双上肢肢端肤色渐变黑，未予重视。
作者 聂晟 贾楠 王国保 刘郑荣
机构地区 南方医科大学南方医院肾内科
出处 《中华肾脏病杂志》 CAS CSCD 北大核心 2013年第8期643-644,共2页 Chinese Journal of Nephrology
关键词 POEMS综合征 血栓性微血管病 肾损害 四肢乏力 颜面浮肿 颜面水肿 性欲减退 麻木感
分类号 R692 [医药卫生—泌尿科学]
  • 相关文献

参考文献9

  • 1Pavord SR, Muwhy PT, Mithchell VE. POEMS syndrome and waldrenstrom' s macroglobulinaemia. J Clin Pathol, 1996, 49: 181-182.
  • 2Scarlato M, Previtali SC, Carpo M, et al. Polyneuropathy in POEMS syndrome: role of angiogenic factors in the pathogenesis. Brain, 2005, 128:1911-1920.
  • 3Aguayo A, Kantarjian H, Manshouri T, et al. Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes. Blood, 2000, 96: 2240-2245.
  • 4Watauabe O, Arimura K, Kitajima I, et al. Greatly raised vascular endothelial growth factor (VEGF ) in POEMS syndrome. Lancet, 1996, 347: 702.
  • 5李世军,陈惠萍,涂远茂,陈樱花,张丽华,刘志红.POEMS综合征相关肾损害临床及病理特征[J].肾脏病与透析肾移植杂志,2012,21(5):429-434. 被引量：9
  • 6Eremina V, Jefferson JA, Kowalewska J, et al. VEGF inhibition and renal thrombotic microangiopathy. N Engl J Med, 2008, 358:1129-1136.
  • 7Bollee G, Patey N, Cazajous G, et al. Thrombotic microangiopathy secondary to VEGF pathway inhibition by sunitinib. Nephrol Dial Transplant, 2009, 24: 682-685.
  • 8Rosti V, Massa M, Campanelli R, et al. Vascular endothelial growth factor promoted endothelial progenitor cell mobilization into the peripheral blood of a patient with POEMS syndrome. Haematologica, 2007, 92: 1291-1292.
  • 9Badros A, Porter N, Zimrin A. Bevacizumab therapy for POEMS syndrome. Blood, 2005, 106:1135.

二级参考文献15

  • 1朱卫国,王玉,曾学军,王强,沈悌.POEMS综合征32例临床分析[J].中华内科杂志,2006,45(2):108-111. 被引量：46
  • 2Scarlato M, Previtali SC. POEMS syndrome: the matter-of-fact approach. Curr Opin Neurol. , 2011,24 ( 5 ) :491 - 496.
  • 3Dispenzieri A, Kyle RA, Lacy MQ, et al. POEMS syndrome : definition and long-term outcome. Blood,2003, 101 (7) :2496 -2506.
  • 4Nakamoto Y, Imai H, Yasuda T, et al. A spectrum of clinicopathological features of nephropathy associated with POEMS syndrome. Nephrnl Dial Transplant, 1999,14 (10) :2370 - 2378.
  • 5Modesto-Segonds A, Rey JP, Orfila C, et al. Renal involvement in POEMS syndrome. Clin Nephrol,1995,43 (5) :342 -345.
  • 6Soubrier M, Sauron C, Souweine B, et al. Growth fact ors and proinflammatory cytokines in the renal involvement of POEMS syndrome. Am J Kindey Dis, 1999,34 (4) :633 - 638.
  • 7Li J,Zhou DB, Huang Z, et al. Clinical characteristics and long-term outcome of patients with POEMS syndrome in China. Ann Hematol, 2011,90(7) :819 -826.
  • 8Fukatsu A,Tamai H,Nishikawa K, et al. The kidney disease of Crow- Fukase (POEMS) syndrome: a clinico-pathological study of four cases. Clin Nephrol, 1991,36(2) :76 - 82.
  • 9Watanabe O, Afimura K, Kitajima I, et al. Greatly raised vascular endothelial growth factor (VEGF) in POEMS syndrome. Lancet, 1996,347 ( 9002 ) : 702.
  • 10Storkebaum E, Lambrechts D, Dewerchin M, et al. Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS. Nat Neurosci ,2005,8( 1 ) :85 -92.

共引文献8

同被引文献11

引证文献4

二级引证文献3

中华肾脏病杂志
2013年 第8期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部